Journal of Adolescent Health
Volume 35, Issue 6 , Pages 505-508 , December 2004

Seroprevalence of hepatitis C among a juvenile detention population

  • Gary M. Feldman, M.D. (F.A.A.P., F.A.B.M.G.)

      Affiliations

    • Department of Public Health, County of Riverside, Riverside, California, USA
    • ,
  • Frank Sorvillo, Ph.D.

      Affiliations

    • Department of Epidemiology, School of Public Health, University of California, Los Angeles, Los Angeles, California, USA
    • Corresponding Author InformationAddress correspondence to: Dr. Frank Sorvillo, Department of Epidemiology, School of Public Health, UCLA, Box 951772, Los Angeles, CA 90095-1772 USA
    • ,
  • Barbara Cole, M.S.N.

      Affiliations

    • Department of Public Health, County of Riverside, Riverside, California, USA
    • ,
  • William A. Lawrence, M.P.H.

      Affiliations

    • Department of Public Health, County of Riverside, Riverside, California, USA
    • ,
  • Rebecca Mares, B.S.

      Affiliations

    • Department of Public Health, County of Riverside, Riverside, California, USA

,Accepted 4 February 2004.

References 

  1. Lauer GM, Walder BD. Medical progress (Hepatitis C virus infection). N Engl J Med. 2001;345:41–52
  2. Centers for Disease Control and Prevention . Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47:1–39
  3. http://www.cdc.gov/ncidod/diseases/hepatitis/c/fact.htm. Accessed November 13, 2003
  4. Alter MJ, Kruszon-Moran D, Nainan OV, et al.  The prevalence of hepatitis C virus infection in the United States 1988 through 1994. N Engl J Med. 1999;341:556–562
  5. Alter MJ, Margolis HS, Krawczynski K, et al.  The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 1992;327:1899–1905
  6. Davis GL, Esteban-Mur R, Rustgi V, et al.  International Hepatitis Interventional Therapy Group   Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med. 1998;339:1493–1499
  7. Murray KF, Richardson LP, Morishima C, et al.  Prevalence of Hepatitis C virus infection and risk factors in an incarcerated juvenile population (A pilot study). Pediatrics. 2003;111:153–157
  8. Ogilvie EL, Veit F, Crofts N, Thompson SC. Hepatitis infection among adolescents resident in Melbourne Juvenile Justice Centre (Risk factors and challenges). J Adolesc Health. 1999;25:46–51
  9. Krajden M. Hepatitis C diagnosis and testing. Can J Public Health. 2000;91(Suppl 1):S34–S39

PII: S1054-139X(04)00072-2

doi: 10.1016/j.jadohealth.2004.02.007

Journal of Adolescent Health
Volume 35, Issue 6 , Pages 505-508 , December 2004

Article Tools